Business Context and Reporting Period
This Form 8-K, filed on February 10, 2020, by McKesson Corporation (MCK), announces the commencement of an Exchange Offer to separate the Company's interest in Change Healthcare. The filing details the "Transactions," which include the Exchange Offer, a potential pro rata Spin-off of remaining shares, and a subsequent Merger of PF2 SpinCo, Inc. with Change Healthcare Inc. The goal is to distribute McKesson's interest in the joint venture to its shareholders, resulting in Change Healthcare becoming an independent public company.
Key Financial Metrics
This filing is a Current Report regarding a material definitive agreement and corporate action; it does not contain periodic financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics for McKesson Corporation or Change Healthcare. The document focuses on the structural and legal terms of the separation rather than operational financial results.
Material Changes and Transaction Structure
- Exchange Offer: McKesson is offering holders of its common stock the option to exchange shares for shares of SpinCo common stock, which holds McKesson's interest in Change Healthcare.
- Clean-up Spin-off: If the Exchange Offer is not fully subscribed, remaining SpinCo shares will be distributed pro rata to McKesson shareholders.
- Merger: Following the distribution, SpinCo will merge with Change Healthcare. Post-transaction, McKesson shareholders participating in the offer or spin-off will own approximately 51% of Change Healthcare on a fully-diluted basis.
- Agreements: The Company entered into a Separation and Distribution Agreement and a Tax Matters Agreement on February 10, 2020, governing the transfer of assets, indemnification, and tax liabilities.
Guidance, Risks, and Contingencies
Conditions to Closing: The Transactions are subject to several conditions, including the effectiveness of registration statements (Form S-4 and S-1) filed with the SEC, satisfaction of merger conditions, and receipt of legal opinions confirming the tax-free status of the distribution and merger.
Tax Matters: The Distribution is intended to be tax-free for U.S. federal income tax purposes. If Change Healthcare fails to comply with the Tax Matters Agreement, it may be required to indemnify McKesson or enter into a new tax receivable agreement paying 85% of cash tax savings to McKesson.
Risks and Uncertainties: Forward-looking statements in the filing highlight risks including regulatory changes in the healthcare industry, foreign currency fluctuations, pending legal proceedings (specifically regarding controlled substances), cyberattacks, and the potential failure to complete the Transactions on anticipated terms. The filing explicitly states that actual results may differ materially from expectations.
Investor Verification Checklist
- Verify the terms of the Exchange Offer and the exchange ratio in the official prospectus (Schedule TO) and registration statements (Form S-4/S-1) referenced in the filing.
- Confirm the status of the SEC registration statements (File Nos. 333-236236 and 333-236234) to ensure they have been declared effective.
- Review the Separation and Distribution Agreement (Exhibit 2.1) for specific indemnification obligations and liability allocations between McKesson and Change Healthcare.
- Assess the tax implications for shareholders, noting the intent for tax-free treatment and the conditions required to maintain that status.
- Monitor the timeline for the Merger and the potential for a "clean-up" spin-off if the Exchange Offer is not fully subscribed.